Core Clinical Laboratory for Type 1 diabetes Research Trials

The University of South Florida, on behalf of TrialNet, is seeking to establish one or more core laboratories to provide clinical testing for safety, eligibility, and endpoint assessment for Type 1 Diabetes clinical research trials. The selected laboratory will perform various assays, including diabetes-related autoantibodies, metabolic assessments, and viral serology. The laboratory will be required to submit a proposal, including performance of all or some of the listed assays, and demonstrate their ability to perform accurate and precise measurements. The contract will be renewed annually while TrialNet funding continues, and the budget will be adjusted based on projected assay volumes each year. Key points to consider: • The contract involves clinical testing for Type 1 Diabetes research trials • The selected laboratory will perform various assays, including diabetes-related autoantibodies and metabolic assessments • The contract will be renewed annually while TrialNet funding continues • The budget will be adjusted based on projected assay volumes each year • The laboratory will be required to submit a proposal and demonstrate their ability to perform accurate and precise measurements